Low-molecular weight heparin versus vitamin K antagonists for the treatment of cancer-associated thrombosis: A cost-effectiveness analysis.

Persons

Gregory Abel

Venue / Journal

Thromb Res

Date

Wed, 02/01/2017 - 12:00

Additional Journal Information

150:53-58

Authors

Connell NT, Abel GA, Connors JM.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/28039844